Project Details
| Status | Active |
|---|---|
| Effective start/end date | 21/04/26 → 20/04/31 |
Clinical Trial Phase
- Phase II
- External Sponsor
An ALLG phase II trial of epcoritamab consolidation in high genomic risk and MRD+ CLL patients after first-line venetoclax + obinutuzumab.
- Opat, Stephen (Primary Chief Investigator (PCI))
Project: Research